A Study of AZD4901 in Females With Polycystic Ovary Syndrome
To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome
Polycystic Ovary Syndrome (PCOS), Female Endocrine Disorder
DRUG: AZD4901 (oral)|DRUG: Placebo to match AZD4901
Lutenising Hormone (LH) AUC(0-8) Ratio to Baseline at Day 7, Change-from-baseline of luteinising hormone area under the concentration-time curve from time zero to 8 hours postdose \[AUC(0-8)\] at Day 7, Day 7
To assess the effects of AZD4901 when given in multiple doses to females with Polycystic Ovary Syndrome